Neurophysiological MEG markers of cognitive impairment and performance validity in multiple sclerosis

Autor: Shira Simon, Ilse M Nauta, Arjan Hillebrand, Menno M Schoonheim, Bernard MJ Uitdehaag, Maureen van Dam, Hanneke E Hulst, Martin Klein, Cornelis J Stam, Brigit A de Jong, Eva MM Strijbis
Přispěvatelé: Neurology, Amsterdam Neuroscience - Brain Imaging, Amsterdam Neuroscience - Systems & Network Neuroscience, Anatomy and neurosciences, Amsterdam Neuroscience - Neuroinfection & -inflammation, Medical psychology, CCA - Cancer Treatment and quality of life, Amsterdam Neuroscience - Neurodegeneration, APH - Quality of Care
Jazyk: angličtina
Rok vydání: 2023
Předmět:
Zdroj: Multiple Sclerosis Journal. SAGE Publications Ltd
Simon, S, Nauta, I M, Hillebrand, A, Schoonheim, M M, Uitdehaag, B M J, van Dam, M, Hulst, H E, Klein, M, Stam, C J, de Jong, B A & Strijbis, E M M 2023, ' Neurophysiological MEG markers of cognitive impairment and performance validity in multiple sclerosis ', Multiple Sclerosis Journal . https://doi.org/10.1177/13524585231159817
ISSN: 1352-4585
DOI: 10.1177/13524585231159817
Popis: Background: Suboptimal performance during neuropsychological testing frequently occurs in multiple sclerosis (MS), leading to unreliable cognitive outcomes. Neurophysiological alterations correlate with MS-related cognitive impairment, but studies have not yet considered performance validity. Objectives: To investigate neurophysiological markers of cognitive impairment in MS, while explicitly addressing performance validity. Methods: Magnetoencephalography recordings, neuropsychological assessments, and performance validity testing were obtained from 90 MS outpatients with cognitive complaints. Spectral and resting-state functional connectivity (rsFC) properties were compared between cognitively impaired (CI), cognitively preserved (CP), and suboptimally performing (SUB) patients using regression models and permutation testing. Results: CI had higher power in low-frequency bands and lower power in high bands compared to CP, indicating neuronal slowing. CI also showed lower beta power compared to SUB. Overall power spectra visually differed between CI and CP, and SUB showed overlap with both groups. CI had lower rsFC than CP and SUB patients. CP and SUB patients showed no differences. Conclusion: Neuronal slowing and altered rsFC can be considered cognitive markers in MS. Patients who performed suboptimally showed resemblance with patients with and without cognitive impairments, and although their overall neurophysiological profile was more similar to patients without impairments, it suggests heterogeneity regarding their pathophysiology.
Databáze: OpenAIRE
Externí odkaz: